This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Oregon Health & Science University, Sanofi Pasteur Inc.. Active years: 2019-2021.
Company Filing History:
4 out of 524 
3 out of 168 
Years Active: 2019-2021
Title: Ted Milburn Ross: Innovator in Influenza Research
Introduction
Ted Milburn Ross is a notable inventor based in Watkinsville, GA (US). He has made significant contributions to the field of influenza research, holding a total of 4 patents. His work focuses on the development of innovative immunogenic compositions aimed at enhancing protective immunity against various strains of influenza.
Latest Patents
Among his latest patents, Ross has developed methods for the synergistic co-administration of computationally optimized broadly reactive antigens for H1N1 influenza. This invention provides a means for the co-administration of optimized H1N1 influenza hemagglutinin (HA) polypeptides, facilitating synergistic neutralization of viral infection. This approach aims to improve protective immunity against diverse H1N1 influenza virus strains, including both seasonal and pandemic variants. Additionally, he has patented a similar method for the H5N1 influenza virus, which also focuses on the co-administration of optimized HA polypeptides to enhance immune response against multiple H5N1 clades and strains.
Career Highlights
Throughout his career, Ross has worked with prominent organizations such as Oregon Health & Science University and Sanofi Pasteur Inc. His research has been pivotal in advancing the understanding and treatment of influenza viruses, contributing to public health initiatives.
Collaborations
Ross has collaborated with notable colleagues in his field, including Donald Martin Carter, Jr. and Tim Alefantis. These partnerships have further enriched his research and innovation efforts.
Conclusion
Ted Milburn Ross stands out as a key figure in influenza research, with a focus on developing innovative solutions to combat viral infections. His contributions through patents and collaborations continue to impact the field significantly.